RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Medical Ikkou Group Co Stock

Medical Ikkou Group Co Revenue 2024

Medical Ikkou Group Co Revenue

39.9 B JPY

Ticker

3353.T

ISIN

JP3921040006

In 2024, Medical Ikkou Group Co's sales reached 39.9 B JPY, a 17.71% difference from the 33.9 B JPY sales recorded in the previous year.

The Medical Ikkou Group Co Revenue history

YEARREVENUE (undefined JPY)GROSS MARGIN (%)
202439.911,41
202333.99,39
202233.610,76
202131.610,14
202032.0410,74
201931.2210,46
201830.9111,32
201729.4911,09
201629.3110,93
201526.3911,24
201422.8711,10
201320.5810,96
201219.5811,64
201117.9710,79
201017.1910,88
200916.0710,20
200814.6610,46
200712.369,14
200610.5610,12
20059.2710,96

Medical Ikkou Group Co Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Medical Ikkou Group Co, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Medical Ikkou Group Co from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Medical Ikkou Group Co’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Medical Ikkou Group Co. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Medical Ikkou Group Co’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Medical Ikkou Group Co’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Medical Ikkou Group Co’s growth potential.

Medical Ikkou Group Co Revenue, EBIT and net profit per share

DateMedical Ikkou Group Co RevenueMedical Ikkou Group Co EBITMedical Ikkou Group Co Net Income
202439.9 B undefined1.56 B undefined1.04 B undefined
202333.9 B undefined935.17 M undefined759.6 M undefined
202233.6 B undefined1.28 B undefined852.33 M undefined
202131.6 B undefined1.03 B undefined834.99 M undefined
202032.04 B undefined1.2 B undefined801.99 M undefined
201931.22 B undefined1.04 B undefined711.65 M undefined
201830.91 B undefined1.41 B undefined1.24 B undefined
201729.49 B undefined1.2 B undefined956.04 M undefined
201629.31 B undefined1.43 B undefined910.58 M undefined
201526.39 B undefined1.27 B undefined797.47 M undefined
201422.87 B undefined1.26 B undefined686 M undefined
201320.58 B undefined1.1 B undefined791 M undefined
201219.58 B undefined1.21 B undefined624 M undefined
201117.97 B undefined989 M undefined513 M undefined
201017.19 B undefined976 M undefined457 M undefined
200916.07 B undefined750 M undefined329 M undefined
200814.66 B undefined712 M undefined289 M undefined
200712.36 B undefined428 M undefined46 M undefined
200610.56 B undefined417 M undefined177 M undefined
20059.27 B undefined402 M undefined166 M undefined

Medical Ikkou Group Co stock margins

The Medical Ikkou Group Co margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Medical Ikkou Group Co. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Medical Ikkou Group Co.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Medical Ikkou Group Co's sales revenue. A higher gross margin percentage indicates that the Medical Ikkou Group Co retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Medical Ikkou Group Co's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Medical Ikkou Group Co's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Medical Ikkou Group Co's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Medical Ikkou Group Co. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Medical Ikkou Group Co's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Medical Ikkou Group Co Margin History

Medical Ikkou Group Co Gross marginMedical Ikkou Group Co Profit marginMedical Ikkou Group Co EBIT marginMedical Ikkou Group Co Profit margin
202411.41 %3.91 %2.61 %
20239.39 %2.76 %2.24 %
202210.76 %3.8 %2.54 %
202110.14 %3.25 %2.64 %
202010.74 %3.76 %2.5 %
201910.46 %3.34 %2.28 %
201811.32 %4.55 %4.01 %
201711.09 %4.07 %3.24 %
201610.93 %4.87 %3.11 %
201511.24 %4.81 %3.02 %
201411.1 %5.5 %3 %
201310.96 %5.35 %3.84 %
201211.64 %6.2 %3.19 %
201110.79 %5.5 %2.85 %
201010.88 %5.68 %2.66 %
200910.2 %4.67 %2.05 %
200810.46 %4.86 %1.97 %
20079.14 %3.46 %0.37 %
200610.12 %3.95 %1.68 %
200510.96 %4.34 %1.79 %

Medical Ikkou Group Co Aktienanalyse

What does Medical Ikkou Group Co do?

Medical Ikkou Group Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Revenue Details

Understanding Medical Ikkou Group Co's Sales Figures

The sales figures of Medical Ikkou Group Co originate from the total revenue accrued from goods sold or services provided during a specific time period. These numbers are a direct reflection of the company’s ability to translate its products or services into revenue, indicating the demand and market presence.

Year-to-Year Comparison

Analyzing Medical Ikkou Group Co’s yearly sales data offers insights into the company’s growth and stability. An increase in sales suggests a growing demand for its offerings, efficient marketing, or expansion into new markets. Conversely, a decline might indicate market saturation, increased competition, or less effective strategies.

Impact on Investments

Investors often scrutinize Medical Ikkou Group Co's sales data to evaluate its financial health and growth prospects. Consistent sales growth can be a promising indicator of the company’s profitability and potential return on investment, influencing stock prices and investor confidence.

Interpreting Sales Fluctuations

Increases in Medical Ikkou Group Co’s sales indicate market growth, innovation, or effective marketing, often leading to a surge in stock prices. A decline, however, can signal challenges requiring strategic adjustments to enhance market share and profitability.

Frequently Asked Questions about Medical Ikkou Group Co stock

How much revenue did Medical Ikkou Group Co generate this year?

Medical Ikkou Group Co has achieved a revenue of 39.9 B JPY this year.

How much was the turnover of the company Medical Ikkou Group Co compared to the previous year?

The revenue of Medical Ikkou Group Co has increased by 17.71% increased compared to the previous year.

What does revenue mean for investors?

The revenue of a company is an important indicator of its financial performance and attractiveness for investors.

Which factors influence the revenue of Medical Ikkou Group Co?

The revenue of Medical Ikkou Group Co is influenced by various factors, including the demand for its products and services, market conditions, and prices.

How is the revenue of Medical Ikkou Group Co measured?

Revenue is typically measured in units referring to the sale of goods and services provided by the company.

How does an increase in sales affect investments?

An increase in revenue can prompt investors to invest more money in the company as it serves as a positive signal for its financial performance and growth prospects.

What are the possible risks associated with a declining revenue?

A decline in revenue can prompt investors to invest less money in the company, as it is a negative signal for its financial performance and growth prospects.

Why is the sales revenue of Medical Ikkou Group Co so important for investors?

The revenue of Medical Ikkou Group Co is an important indicator of financial performance and attractiveness for investors.

What strategic measures can a company take to increase revenue?

A company can take various strategic measures to increase revenue, including developing new products and services, introducing new pricing models, and expanding into new markets.

How much dividend does Medical Ikkou Group Co pay?

Over the past 12 months, Medical Ikkou Group Co paid a dividend of 50 JPY . This corresponds to a dividend yield of about 1.84 %. For the coming 12 months, Medical Ikkou Group Co is expected to pay a dividend of 50 JPY.

What is the dividend yield of Medical Ikkou Group Co?

The current dividend yield of Medical Ikkou Group Co is 1.84 %.

When does Medical Ikkou Group Co pay dividends?

Medical Ikkou Group Co pays a quarterly dividend. This is distributed in the months of September, March, September, March.

How secure is the dividend of Medical Ikkou Group Co?

Medical Ikkou Group Co paid dividends every year for the past 20 years.

What is the dividend of Medical Ikkou Group Co?

For the upcoming 12 months, dividends amounting to 50 JPY are expected. This corresponds to a dividend yield of 1.84 %.

In which sector is Medical Ikkou Group Co located?

Medical Ikkou Group Co is assigned to the 'Non-cyclical consumption' sector.

Wann musste ich die Aktien von Medical Ikkou Group Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Medical Ikkou Group Co from 11/1/2024 amounting to 25 JPY, you needed to have the stock in your portfolio before the ex-date on 8/29/2024.

When did Medical Ikkou Group Co pay the last dividend?

The last dividend was paid out on 11/1/2024.

What was the dividend of Medical Ikkou Group Co in the year 2023?

In the year 2023, Medical Ikkou Group Co distributed 40 JPY as dividends.

In which currency does Medical Ikkou Group Co pay out the dividend?

The dividends of Medical Ikkou Group Co are distributed in JPY.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Medical Ikkou Group Co

Our stock analysis for Medical Ikkou Group Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Medical Ikkou Group Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.